NCT05952635

Brief Summary

Nephrolithiasis is the most common chronic kidney condition and affecting approximately one in every 10-17 people in the world\[1,2\]. Flexible ureteroscopy (f-URS) has become one of the most common treatments for ureteral and renal stones with minimal complications. The development of ureteral access sheath (UAS) is a significant advance in flexible ureteroscopic management of urinary stones. The UAS has two major advantages: 1) facilitating multiple entries into the renal collecting system without causing recurrent trauma to the ureter and permit expeditious basketing of multiple stone fragments, 2) improving the irrigation with better fluid outflow, thereby reducing the renal pelvic pressure (RPP) and risk of infectious complications. The tip bendable suction ureteral access sheath (S-UAS) is a novel UAS that has good flexibility and deformability at the tip, which can passively bend (bend \>90°) with the bending of f-URS and can connect to a vacuum suction device. Preliminary study showed that S-UAS can follow f-URS to cross the UPJ and into the renal pelvis and calices. S-UAS close to the stone can achieve complete stone-free status in RIRS. However, further clinical studies and comparisons with available techniques are required. This prospective, single-blinded, single-center, randomized control trial will evaluate the stone free rates, operative time, postoperative complications following RIRS with S-UAS. To the best of our knowledge, this is the first study to compare the clinical benefits of RIRS with S-UAS and traditional UAS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 19, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

August 2, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2024

Completed
Last Updated

June 25, 2024

Status Verified

June 1, 2024

Enrollment Period

7 months

First QC Date

June 17, 2023

Last Update Submit

June 22, 2024

Conditions

Keywords

Kidney stoneFlexible ureteroscopyUreteral access sheath

Outcome Measures

Primary Outcomes (1)

  • Immediate stone-free rate

    No residual stone, or no stone fragments larger than 2 mm on KUB and ultrasound at postoperative day 1 are defined as stone free.

    Postoperative day 1

Secondary Outcomes (6)

  • Stone-free rate at 3 months

    Postoperative 3 month

  • Duration of hospital stay

    From date of operation until the date of discharge, assessed up to 2 weeks.

  • Further interventions received up to 3 months post randomization

    Postoperative 3 month

  • Complications up to 3 months post randomization

    Postoperative 3 month

  • Change of Quality of life Score (prior to surgery and at month 3 after randomization)

    Postoperative 3 month

  • +1 more secondary outcomes

Study Arms (2)

Tip bendable suction ureteral access sheath (S-UAS) group

EXPERIMENTAL

Patients will use S-UAS during flexible ureteroscopy.

Procedure: Tip bendable suction ureteral access sheath

Traditional ureteral access sheath group

NO INTERVENTION

Patients will use traditional UAS during flexible ureteroscopy.

Interventions

Patient use tip bendable suction ureteral access sheath during flexible ureteroscopy to see if flexible ureteroscopy with S-UAS offers the better treatment outcomes in terms of clinical effectiveness and post-operative complications.

Tip bendable suction ureteral access sheath (S-UAS) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged ≥ 18 years;
  • American Society of Anesthesiology score 1-3;
  • Upper urinary stone (kidney stone or upper ureteral stone) diameter of ≤ 3 cm confirmed by CT;
  • Capable of giving written informed consent, which includes adherence with the requirements of the trial.

You may not qualify if:

  • Patients with abnormal urinary tract anatomy (such as horseshoe kidney or ileal conduit);
  • Patients with uncontrolled UTI;
  • Patients with health or other factors that are absolute contraindications to RIRS;
  • Patients unable to understand or complete trial documentation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Urology, The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, 510230, China

Location

Related Publications (1)

  • Zhu W, Liu S, Cao J, Wang H, Liang H, Jiang K, Cui Y, Chai CA, Sahinler EB, Aquino A, Mazzon G, Zhong W, Zhao Z, Zhang L, Ding J, Wang Q, Wang Y, Chen KW, Liu Y, Choong S, Sarica K, Zeng G. Tip bendable suction ureteral access sheath versus traditional sheath in retrograde intrarenal stone surgery: an international multicentre, randomized, parallel group, superiority study. EClinicalMedicine. 2024 Jul 5;74:102724. doi: 10.1016/j.eclinm.2024.102724. eCollection 2024 Aug.

MeSH Terms

Conditions

Kidney Calculi

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice president

Study Record Dates

First Submitted

June 17, 2023

First Posted

July 19, 2023

Study Start

August 2, 2023

Primary Completion

February 28, 2024

Study Completion

June 21, 2024

Last Updated

June 25, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations